Keymed Biosciences Inc. — Share Issue/Capital Change 2021

Apr 8, 2021

Application Proof

	Keymed Biosciences Inc.
	YOU SHOULD READ THE WARNING IN THE DOCUMENT.

 

►	Warning
►	Important
►	Expected Timetable
►	Table of Contents
►	Summary
►	Definitions
►	Glossary of Technical Terms
►	Forward-looking Statements
►	Risk Factors
►	Waivers from Strict Compliance with the Listing Rules and Exemptions from Compliance with the Companies (Winding Up and Miscellaneous Provisions) Ordinance
►	Information about this Document and the [REDACTED]
►	Directors and Parties Involved in the [REDACTED]
►	Corporate Information
►	Industry Overview
►	Regulatory Overview
►	History, Development and Corporate Structure
►	Business
►	Financial Information
►	Relationship with our Controlling Shareholders
►	Share Capital
►	Substantial Shareholders
►	Directors and Senior Management
►	Future Plans and Use of [REDACTED]
►	[REDACTED]
►	Structure of the [REDACTED]
►	How to Apply for the [REDACTED]
►	Appendix I - Accountants' Report
►	Appendix II - Unaudited Pro Forma Financial Information
►	Appendix III - Summary of the Constitution of the Company and Cayman Islands Company Law
►	Appendix IV - Statutory and General Information
►	Appendix V - Documents Delivered to the Registrar of Companies and Available for Inspection